Rhythm Pharmaceuticals Inc (STU:1RV)
€ 37.86 -0.03 (-0.08%) Market Cap: 2.38 Bil Enterprise Value: 2.20 Bil PE Ratio: 0 PB Ratio: 41.42 GF Score: 52/100

Q2 2021 Rhythm Pharmaceuticals Inc Earnings Call Transcript

Aug 03, 2021 / 12:00PM GMT
Release Date Price: €13.8 (-4.83%)
Operator

Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals Q2 2021 Earnings Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, David Connolly, Head of Investor Relations and Corporate Communications at Rhythm. Thank you. Please go ahead.

David Connolly
Rhythm Pharmaceuticals, Inc. - Head of IR & Corporate Communications

Thank you. Good morning. I'm David Connolly, Head of IR and Corporate Communications here at Rhythm Pharmaceuticals. With me today for our second quarter financial results and business update conference call are David Meeker, Chair, President and Chief Executive of Rhythm Pharmaceuticals; Murray Stewart, our Chief Medical Officer; Jennifer Chien, Executive Vice President, Head of North America; Yann Mazabraud, Executive Vice President, Head of International, who is dialing in from Europe this morning; and Hunter Smith, our Chief Financial Officer, who is here in Boston with us.

For those of you participating via conference call, the accompanying slides can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot